Physician

Derek A Hausladen, M.D.

According to 2025 Medicare claims, Derek Hausladen, M.D. (NPI: 1730195074) practices urology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is LIFESPAN PHYSICIAN GROUP OF MASSACHUSETTS INC (NPI: 1235957713; TIN: 331237732) and primary practice location at 02747-1242. Hausladen is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and CareMax Accountable Care Network, LLC (ACO ID: A5080), participating under the MSSP model.

Hausladen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,456 traditional Medicare patients, billed 7,572 HCPCS/CPT codes, and received $414,672 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 4,051 prescription claims across 1,015 beneficiaries totaling $611,655 in drug costs, led by Xtandi (Enzalutamide). DME data shows 106 claims. Open Payments data shows 2 records totaling $154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $164,463 to $611,655. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $851 and ending at $1,369.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$248K$497K2015 Medicare payment: $348,713 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $334,590 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $419,199 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $420,814 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $468,033 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $422,648 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $496,512 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $415,250 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $414,096 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $414,672 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2287,168$348,713
20161,2726,489$334,590
20171,4708,036$419,199
20182,27110,199$420,814
20192,12912,027$468,033
20201,6049,335$422,648
20211,50612,564$496,512
20221,3679,905$415,250
20231,4239,053$414,096
20241,4567,572$414,672

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$306K$612K2015 Drug cost: $164,463 (USD; Tot_Drug_Cst)2016 Drug cost: $159,000 (USD; Tot_Drug_Cst)2017 Drug cost: $160,047 (USD; Tot_Drug_Cst)2018 Drug cost: $213,152 (USD; Tot_Drug_Cst)2019 Drug cost: $247,105 (USD; Tot_Drug_Cst)2020 Drug cost: $231,831 (USD; Tot_Drug_Cst)2021 Drug cost: $380,084 (USD; Tot_Drug_Cst)2022 Drug cost: $446,871 (USD; Tot_Drug_Cst)2023 Drug cost: $530,903 (USD; Tot_Drug_Cst)2024 Drug cost: $611,655 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155772,708$164,463
20166192,637$159,000
20177313,128$160,047
20187823,365$213,152
20197913,374$247,105
20208263,633$231,831
20218633,771$380,084
20228673,699$446,871
20239033,631$530,903
20241,0154,051$611,655

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$44K2015 Medicare payment: $11,842 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $10,325 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $16,556 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $16,574 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $22,017 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $19,213 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $23,652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $18,390 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $28,623 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $44,296 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201511117$11,842
201612148$10,325
201716131$16,556
201814148$16,574
201916201$22,017
202014176$19,213
202113151$23,652
20221192$18,390
202316126$28,623
202416106$44,296

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
52000Diagnostic exam of bladder and urethra using an endoscope212252$179
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,1361,659$93
76770Complete ultrasound scan behind abdominal cavity429472$81
51798Ultrasound measurement of bladder capacity after voiding658835$9
81003Automated urinalysis test499582$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide12360$172,880
GemtesaVibegron1037,902$122,570
MyrbetriqMirabegron876,780$100,037
NitrofurantoinNitrofurantoin14367$27,526
Tamsulosin HclTamsulosin Hcl1,222101,304$25,298

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachN1669$29,281
A4353Intermittent urinary catheter, with insertion suppliesNN/R13$14,585
A4358Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, eachNN/R13$298
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R11$132

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$154Calyxo, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Derek A. Hausladen, M.D.?

Tedicare shows public-source Medicare data for Derek A. Hausladen, M.D. (NPI 1730195074), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derek A. Hausladen, M.D. have ACO affiliation data?

Derek A. Hausladen, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080).

What billing organization is linked to Derek A. Hausladen, M.D.?

Derek A. Hausladen, M.D. is linked to LIFESPAN PHYSICIAN GROUP OF MASSACHUSETTS INC (billing NPI 1235957713) in the available physician profile data.

Does Derek A. Hausladen, M.D. have Open Payments data?

Derek A. Hausladen, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.